highly potent and selective PPAR-α agonist known as LY518674 in patients with lipid disorders. In the first study, 309 patients with atherogenic dyslipidemia (mean age 54.2 years, 68.9% men ...

The following is a summary of “Metabolic complications and clinical outcomes of non-functioning adrenal incidentalomas: a ...

Triglycerides are a vital source of energy, but when levels become dangerously high, they can lead to serious health ...

PSORIASIS is a chronic inflammatory skin disease influenced by both genetic and environmental factors, affecting ...

With this vision, Sukh Dev and his team delivered powerful solutions to treat lipid disorders and minimise the risk of early pregnancy loss, and also found cures for parasites plaguing livestock ...

A unique form of treatment has the ability to filter the LDL out of a patient's bloodstream. However, it is only available at ...

This radical new way of the regulation of chloride co-transporter activity linked with membrane lipid expression suggests new therapeutical strategies to treat epilepsy. By increasing the general ...

Future research should continue to explore PTGA-related mechanisms and therapies, advancing our knowledge and treatment ...

Time-restricted feeding (TRF) benefits metabolic health, yet sex differences in its effects are often overlooked. A study by ...

A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common chronic diseases like heart disease, diabetes, and cancer. A new process ...